Cancer Cell Detection Equipment
-
Manufactured by Radiopharm Theranosticsbased in AUSTRALIA
PTPµ (PTPmu) is a peptide molecule biomarker, invented by Dr Susann Brady-Kalnay at Case Western Reserve University in Ohio. ...
-
Manufactured by Rarecells Diagnostics SASbased in FRANCE
Cancer is the second cause of death, accounting for nearly 9 million deaths in 2017 all over the world. In 2019, 1,762,450 new cancer cases and 606,880 cancer deaths are projected to occur in the United States. It is estimated that metastasis is the primary cause of 90% of all cancer-related deaths. Circulating Tumor ...
-
Manufactured by IMB Dx, Inc.based in SOUTH KOREA
Tissue specimens are either from surgical resections or biopsies which may raise the risk of bleeding, and infection and further require recovery from the procedure. Genomic profiling of tissue samples provides a single point in space and time which is lacking the ability to reveal tumor heterogeneity and to test repeatedly to monitor the treatment efficacy. The risk of tissue biopsy is much ...
-
Manufactured by Olympia Diagnostics, Inc.based in USA
A prognostic test kit quantitatively measures the expression levels of a panel of cancer recurrence-associated biomarkers in patient urine sample or biopsy tissue sample to predict cancer recurrence and patient ...
-
Manufactured by Olympia Diagnostics, Inc.based in USA
A diagnostic test kit quantitatively measures the expression levels of a panel of prostate cancer-specific biomarkers in patient urine sample or biopsy tissue sample to distinguish prostate cancer from benign patients or normal ...
-
Manufactured by Olympia Diagnostics, Inc.based in USA
A prognostic test kit quantitatively measures the expression levels of a panel of metastasis-specific biomarkers in patient urine sample or biopsy tissue sample to detect existing metastatic prostate cancer and predict prostate cancer that will become metastatic in the ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you